Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment

Detalles Bibliográficos
Autores principales: Vellas, Camille, Kamar, Nassim, Izopet, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307285/
https://www.ncbi.nlm.nih.gov/pubmed/35878684
http://dx.doi.org/10.1016/j.jinf.2022.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307285/
https://www.ncbi.nlm.nih.gov/pubmed/35878684
http://dx.doi.org/10.1016/j.jinf.2022.07.014

Ejemplares similares